Drug profile · INN
agomelatine
VALDOXAN
agomelatine (VALDOXAN) is a melatonin receptor agonist.
EMA: approved Nervous system (N06) N06AX22
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — agomelatine
- Class
- Nervous system (N06)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
agomelatine (VALDOXAN) is a melatonin receptor agonist.
Key facts
INN agomelatine
Brand VALDOXAN
Mechanism Melatonin receptor agonist
Target Melatonin receptor
Therapeutic class Nervous system (N06)
ATC code N06AX22
Mechanism of action
Melatonin receptor agonist
Primary target: Melatonin receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is agomelatine?
agomelatine (VALDOXAN) is a melatonin receptor agonist.
What is the brand name for agomelatine?
VALDOXAN is a marketed brand name for agomelatine. Check FDA Drugs@FDA for the current US label holder and prescribing information.